Tartu Observatory is in a consortium of scientific institutions and private companies to prepare a set of three space missions to Venus to search for signs of life in its atmosphere. The project is expected to conclude with a return of samples from the Venusian atmosphere to Earth.
University of Tartu and H2Electro OÜ, a subsidiary of Thule Capital AS, signed a research and development contract under which researchers of the University of Tartu Institute of Chemistry led by Professor Enn Lust will build an electrolyser based on novel technology.
The Estonian health technology enterprise Antegenes has signed a long-term strategic partnership agreement with Everything Genetic Ltd to introduce the genetic tests used for cancer prevention to the healthcare system of the United Kingdom. Together with the agreement, the Estonian enterprise received an investment of 500,000 euros.